{Reference Type}: Systematic Review
{Title}: Conservative Management of Penile and Urethral Lichen Sclerosus: A Systematic Review.
{Author}: Shieh C;Hakam N;Pearce RJ;Nagpal M;Ghaffar U;Guzman JL;Abbasi B;Shaw NM;Jones CP;Breyer BN;
{Journal}: J Urol
{Volume}: 211
{Issue}: 3
{Year}: 2024 Mar 11
{Factor}: 7.6
{DOI}: 10.1097/JU.0000000000003804
{Abstract}: <B>UNASSIGNED: </B>We evaluate the efficacy and safety profiles of currently available conservative management options for penile and urethral lichen sclerosus.<BR><B>UNASSIGNED: </B>A systematic review of existing literature on lichen sclerosus was conducted utilizing the PubMed, Embase, and Web of Science databases. References were assessed for relevance to nonsurgical management of male genital lichen sclerosus by title and abstract by 3 independent reviewers, then reviewed in full and in duplicate by 5 independent reviewers.<BR><B>UNASSIGNED: </B>Seventeen studies describing conservative management of histologically confirmed penile and urethral lichen sclerosus in male patients were included in the final review. We present available evidence supporting the use of 4 major treatment modalities represented in the existing literature: topical corticosteroids, tacrolimus, platelet-rich plasma, and CO2 laser. We also briefly discuss the limited studies on the use of oral acitretin and polydeoxyribonucleotide injections. Outcomes assessed include symptoms, clinical appearance, quality of life, sexual satisfaction, adverse effects, and long-term efficacy of treatment.<BR><B>UNASSIGNED: </B>Topical corticosteroids remain the mainstay of conservative management of penile and urethral lichen sclerosus, with current literature supporting the use of other therapies such as tacrolimus and platelet-rich plasma as alternatives or adjuvant treatments when escalation of treatment is necessary. Future research should further explore the efficacy and safety of newer therapies through additional controlled clinical trials in the targeted population.